Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemia
Karen L. Bride(Cohen Children's Medical Center), David T. Teachey(Children's Hospital of Philadelphia)
Cited by 42
Related Papers
T-cell acute lymphoblastic leukemia
|Hematology|2016|307
Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared with adult and pediatric COVID-19
|Science Immunology|2021|206
MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia
|Blood|2015|103
Loss of TBL1XR1 Disrupts Glucocorticoid Receptor Recruitment to Chromatin and Results in Glucocorticoid Resistance in a B-Lymphoblastic Leukemia Model
|Journal of Biological Chemistry|2014|58